We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Ramsay Health Care Limited is a medical care facilities business based in Australia. Ramsay Health Care shares (RHC) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Ramsay Health Care has a trailing 12-month revenue of around $12.9 billion. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $57.3347 - $71.3734 |
|---|---|
| 50-day moving average | $67.9743 |
| 200-day moving average | $65.638 |
| Target price | $59.39 |
| PE ratio | 36.3759 |
| Dividend yield | $1.515 (2.18%) |
| Earnings per share (TTM) | $1.926 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$69.26
| 1 week (2021-09-17) | -1.14% |
|---|---|
| 1 month (2021-08-24) | 3.40% |
| 3 months (2021-06-25) | 8.27% |
| 6 months (2021-03-25) | 1.93% |
| 1 year (2020-09-24) | 1.23% |
|---|---|
| 2 years (2019-09-24) | 6.16% |
| 3 years (2018-09-24) | 25.95% |
| 5 years (2016-09-23) | -13.59% |
Valuing Ramsay Health Care stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ramsay Health Care's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ramsay Health Care's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Ramsay Health Care shares trade at around 36x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Ramsay Health Care's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.66. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ramsay Health Care's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ramsay Health Care's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.2 billion (£0.0 million).
The EBITDA is a measure of a Ramsay Health Care's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $12.9 billion |
|---|---|
| Operating margin TTM | 5.37% |
| Gross profit TTM | $1.6 billion |
| Return on assets TTM | 2.31% |
| Return on equity TTM | 11.64% |
| Profit margin | 3.49% |
| Book value | 16.596 |
| Market capitalisation | $16 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Ramsay Health Care.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 30.95
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Ramsay Health Care's overall score of 30.95 (as at 12/31/2018) is nothing to write home about – landing it in it in the 44th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Ramsay Health Care is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 7.88/100
Ramsay Health Care's environmental score of 7.88 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Ramsay Health Care is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 18.48/100
Ramsay Health Care's social score of 18.48 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Ramsay Health Care is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 12.59/100
Ramsay Health Care's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Ramsay Health Care is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Ramsay Health Care scored a 1 out of 5 for controversy – the highest score possible, reflecting that Ramsay Health Care has managed to keep its nose clean.
Ramsay Health Care Limited was last rated for ESG on: 2019-01-01.
| Total ESG score | 30.95 |
|---|---|
| Total ESG percentile | 43.7 |
| Environmental score | 7.88 |
| Environmental score percentile | 9 |
| Social score | 18.48 |
| Social score percentile | 9 |
| Governance score | 12.59 |
| Governance score percentile | 9 |
| Level of controversy | 1 |
Dividend payout ratio: 82.79% of net profits
Recently Ramsay Health Care has paid out, on average, around 82.79% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.94% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Ramsay Health Care shareholders could enjoy a 2.94% return on their shares, in the form of dividend payments. In Ramsay Health Care's case, that would currently equate to about A$1.515 per share.
Ramsay Health Care's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 5 September 2021 (the "ex-dividend date").
Over the last 12 months, Ramsay Health Care's shares have ranged in value from as little as $57.3347 up to $71.3734. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Ramsay Health Care's is 0.5086. This would suggest that Ramsay Health Care's shares are less volatile than average (for this exchange).
Ramsay Health Care Limited provides health care services to public and private patients. The company's health care services comprise day surgery procedures and other surgeries, as well as psychiatric care and rehabilitation services. It operates through approximately 460 locations in Australia, the United Kingdom, France, Sweden, Norway, Denmark, Germany, Indonesia, Malaysia, Hong Kong, and Italy. The company was founded in 1964 and is based in Sydney, Australia.
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
We look at some of the biggest and best performing iron ore stocks in Australia.
Shares in the major banks have risen more than 50% in the last 12 months.
Steps to owning and managing China Evergrande Group shares from Australia.
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
